Ketogenic diet for epilepsy treatment

Area of Science:

• Neurology
• Dietary Therapy
• Epilepsy Management

Background:

• The ketogenic diet (KD), a high-fat, low-carbohydrate diet, has been an effective non-pharmacological treatment for intractable childhood epilepsy since 1921.
• Despite its established efficacy and increasing global use, familiarity among neurologists remains limited.
• Recent years have seen the development of alternative KD variants to enhance palatability, reduce side effects, and broaden patient access.

Purpose of the Study:

• To review the historical development of the ketogenic diet.
• To outline the principles and efficacy of various KD formulations.
• To provide an overview of established and emerging dietary therapies for refractory epilepsy.

Main Methods:

• Literature review of the ketogenic diet and its variants.
• Analysis of historical data and clinical studies on KD efficacy.
• Comparison of classic KD, medium-chain triglyceride (MCT) KD, modified Atkins diet, and low glycemic index treatment.

Main Results:

• The classic KD is a well-established therapy for drug-resistant epilepsy.
• Alternative diets like MCT KD, modified Atkins, and low glycemic index treatment offer greater flexibility and improved tolerability.
• These variants expand treatment options for a wider range of refractory epilepsy patients.

Conclusions:

• The ketogenic diet and its variants represent crucial non-pharmacological options for managing intractable epilepsy.
• Understanding the principles and efficacy of different KD formulations is essential for neurologists.
• Continued research and education are vital to optimize the use of these dietary therapies in epilepsy care.